{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:16:13Z","timestamp":1791728173703,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymgmr.2026.101323","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:29:59Z","timestamp":1780072199000},"page":"101323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quality of life after diet liberalization in individuals with phenylketonuria treated with Pegvaliase"],"prefix":"10.1016","volume":"47","author":[{"given":"Chiara","family":"Cazzorla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Gaiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Carretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Gragnaniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Loro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gueraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dorigato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro P.","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto B.","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2026.101323_bb0005","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","article-title":"Phenylketonuria","volume":"376","author":"Blau","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ymgmr.2026.101323_bb0010","article-title":"Global considerations for lifelong management and therapeutic development for phenylketonuria","volume":"27","author":"Longo","year":"2025","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ajhg.2020.06.006","article-title":"The genetic landscape and epidemiology of phenylketonuria","volume":"107","author":"Hillert","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41572-021-00267-0","article-title":"Phenylketonuria","volume":"7","author":"Van Spronsen","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymgmr.2026.101323_bb0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13023-020-01541-2","article-title":"Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe","volume":"15","author":"Lowe","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109125","article-title":"European guidelines on diagnosis and treatment of phenylketonuria: first revision","volume":"145","author":"van Wegberg","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101289","article-title":"Phenylalanine hydroxylase deficiency diagnosis and management: a 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"27","author":"Smith","year":"2025","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13023-020-01391-y","article-title":"PKU dietary handbook to accompany PKU guidelines","volume":"15","author":"MacDonald","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0045","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.3390\/nu12103033","article-title":"Cognitive outcomes and relationships with phenylalanine in phenylketonuria: a comparison between Italian and English adult samples","volume":"12","author":"Romani","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgmr.2026.101323_bb0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13023-023-02917-w","article-title":"Health-related quality of life in a european sample of adults with early-treated classical PKU","volume":"18","author":"Maissen-Abgottspon","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0055","first-page":"39","article-title":"Living with phenylketonuria in adulthood: the PKU ATTITUDE study","volume":"16","author":"Cazzorla","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jimd.12065","article-title":"The neurological and psychological phenotype of adult patients with early-treated phenylketonuria: a systematic review","volume":"42","author":"Burlina","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0065","first-page":"561","article-title":"Psychiatric and cognitive aspects of phenylketonuria: the limitations of diet and promise of new treatments","volume":"10","author":"Ashe","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9681740","article-title":"Cognitive functioning in adults with phenylketonuria in a cohort of Spanish patients","volume":"2023","author":"Luna","year":"2023","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0075","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10198-021-01415-9","article-title":"The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study","volume":"23","author":"Olofsson","year":"2022","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0080","first-page":"157","article-title":"Quality of life in Jordanian adolescents living with PKU, a single-center, cross-sectional, observational study","volume":"85","author":"Al-Hmaid","year":"2025","journal-title":"J. Pediatr. Nurs. Nurs. Care Child. Fam."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0085","article-title":"The role of paternal engagement in phenylketonuria: exploring psychological outcomes in children","volume":"2","author":"Gaiga","year":"2025","journal-title":"JIM"},{"key":"10.1016\/j.ymgmr.2026.101323_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13023-015-0261-6","article-title":"Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients\u2019 and parents\u2019 quality of life: the phenylketonuria \u2013 quality of life (PKU-QOL) questionnaires","volume":"10","author":"Regnault","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13023-015-0294-x","article-title":"Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries","volume":"10","author":"Bosch","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clnesp.2018.06.005","article-title":"The impact of phenylketonuria on PKU patients\u2019 quality of life: using of the phenylketonuria-quality of life (PKU-QOL) questionnaires","volume":"27","author":"Alptekin","year":"2018","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.ymgmr.2026.101323_bb0105","article-title":"Health related quality of life assessment among early-treated Hungarian adult PKU patients using the PKU-QOL adult questionnaire","volume":"23","author":"Barta","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/cch.12727","article-title":"Psychosocial functioning in children with phenylketonuria: relationships between quality of life and parenting indicators","volume":"46","author":"Morawska","year":"2020","journal-title":"Child Care Health Dev."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0115","article-title":"Quality of life in children living with PKU \u2013 a single-center, cross-sectional, observational study from Hungary","volume":"29","author":"Becsei","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0120","article-title":"Cognition and wellbeing in middle-aged early treated people with phenylketonuria: preliminary results and methodological lessons","volume":"41","author":"Thomas","year":"2024","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1477-7525-11-218","article-title":"Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride","volume":"11","author":"Douglas","year":"2013","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.ymgmr.2026.101323_bb0130","author":"Agenzia Italiana del Farmaco"},{"key":"10.1016\/j.ymgmr.2026.101323_bb0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymgme.2018.03.003","article-title":"Pegvaliase for the treatment of phenylketonuria: a pivotal, double-blind randomized discontinuation phase 3 clinical trial","volume":"124","author":"Harding","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2018.03.006","article-title":"PRISM investigators, Pegvaliase for the treatment of phenylketonuria: results of a long-term phase 3 clinical trial program (PRISM)","volume":"124","author":"Thomas","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0150","article-title":"Pegvaliase for the treatment of phenylketonuria: final results of a long-term phase 3 clinical trial program","volume":"39","author":"Harding","year":"2024","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0155","article-title":"Lessons learned from 5 years of pegvaliase in US clinics: a case series","volume":"42","author":"Cooney","year":"2025","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0160","article-title":"P002: improvements in blood phenylalanine and health-related quality of life outcomes among adults with PKU receiving pegvaliase in the OPAL study","volume":"3","author":"McNutt","year":"2025","journal-title":"Genet. Med. Open"},{"key":"10.1016\/j.ymgmr.2026.101323_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108151","article-title":"Pegvaliase therapy for phenylketonuria: real-world case series and clinical insights","volume":"142","author":"Scala","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16508","article-title":"Effect of enzyme substitution therapy on brain magnetic resonance imaging and cognition in adults with phenylketonuria: a case series of three patients","volume":"31","author":"Burlina","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0175","doi-asserted-by":"crossref","DOI":"10.4103\/abr.abr_238_23","article-title":"Quality of life in patients with phenylketonuria: a systematic review","volume":"13","author":"Jahangiri","year":"2024","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0180","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.3390\/nu16183119","article-title":"Factors affecting adherence to a low phenylalanine diet in patients with phenylketonuria: a systematic review","volume":"16","author":"Yagudina","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgmr.2026.101323_bb0185","doi-asserted-by":"crossref","first-page":"e1881","DOI":"10.1542\/peds.2012-3291","article-title":"Long-term follow-up and outcome of phenylketonuria patients on Sapropterin: a retrospective study","volume":"131","author":"Keil","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgmr.2026.101323_bb0190","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1186\/1471-2458-14-1243","article-title":"Quality of life (QoL) assessment in a cohort of patients with phenylketonuria","volume":"14","author":"Cazzorla","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ymgmr.2026.101323_bb0195","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ymgme.2018.07.002","article-title":"The impact of metabolic control and tetrahydrobiopterin treatment on health related quality of life of patients with early-treated phenylketonuria: a PKU-COBESO study","volume":"125","author":"Huijbregts","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0200","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.ymgme.2013.09.015","article-title":"Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study","volume":"110","author":"Demirdas","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0205","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10545-012-9458-1","article-title":"Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of life","volume":"35","author":"Ziesch","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0210","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/apa.13799","article-title":"Sapropterin treatment does not enhance the health-related quality of life of patients with phenylketonuria and their parents","volume":"106","author":"Feldmann","year":"2017","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/87565641.2016.1243109","article-title":"Systematic review and Meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria","volume":"41","author":"Bilder","year":"2016","journal-title":"Dev. Neuropsychol."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0220","article-title":"Use of pegvaliase in the management of phenylketonuria: case series of early experience in US clinics","volume":"28","author":"Adams","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101323_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/nu14030626","article-title":"Hungry for change: the experiences of people with PKU, and their caregivers, when eating out","volume":"14","author":"Poole","year":"2022","journal-title":"Nutrients"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:17:14Z","timestamp":1784906234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426926000352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"alternative-id":["S2214426926000352"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101323","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life after diet liberalization in individuals with phenylketonuria treated with Pegvaliase","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101323"}}